James Hardie Exceeds FY26 Adjusted EBITDA Guidance, Projects Strong FY27 Growth & Free Cash Flow
summarizeSummary
James Hardie Industries exceeded its Adjusted EBITDA guidance for Q4 and full-year FY26 and provided an optimistic FY27 outlook with projected Adjusted EBITDA growth and increased Free Cash Flow, driven by synergy realization.
check_boxKey Events
-
Exceeded FY26 Adjusted EBITDA Guidance
The company reported Q4 FY26 Adjusted EBITDA of $381 million and full-year FY26 Adjusted EBITDA of $1.27 billion, both exceeding prior guidance and expectations.
-
Strong FY27 Outlook
James Hardie is targeting Pro Forma Adjusted EBITDA growth of 4% to 8% in FY27 and expects Free Cash Flow to exceed $500 million, an increase of over $200 million year-over-year.
-
AZEK Acquisition Synergies Ahead of Schedule
Cost synergies from the AZEK acquisition are ahead of schedule, and commercial synergies are on track, reinforcing confidence in long-term value creation from the integration.
-
Significant Net Sales Growth
Net Sales increased 45% year-over-year in Q4 FY26 to $1.40 billion and 25% for the full year to $4.84 billion, primarily driven by the AZEK acquisition.
auto_awesomeAnalysis
James Hardie reported strong adjusted financial results for Q4 and full-year FY26, surpassing its Adjusted EBITDA guidance. The company also provided a positive outlook for FY27, projecting significant growth in Adjusted EBITDA and a substantial increase in Free Cash Flow, driven by successful integration and synergy realization from the AZEK acquisition. While GAAP net income declined due to acquisition-related expenses, the focus on adjusted metrics and future cash generation indicates a solid operational performance in a challenging market.
At the time of this filing, JHX was trading at $18.90 on NYSE in the Manufacturing sector, with a market capitalization of approximately $10.9B. The 52-week trading range was $16.46 to $29.83. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.